$97.44
+0.90
(+0.93%)
As of Oct 7, 2026, 3:09 PM EDT
Price history
Church & Dwight (CHD) is trading up at $97.44 (+0.93%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Consumer Staples sector.
Church & Dwight revenue & net income history (FY2016–FY2025)
RevenueNet income
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.49B | $3.78B | $4.15B | $4.36B | $4.90B | $5.19B | $5.38B | $5.87B | $6.11B | $6.20B |
| Growth (year over year) | +2.9% | +8.1% | +9.8% | +5.1% | +12.3% | +6.0% | +3.6% | +9.2% | +4.1% | +1.6% |
| Gross profit | $1.59B | $1.73B | $1.84B | $1.98B | $2.21B | $2.26B | $2.25B | $2.59B | $2.79B | $2.77B |
| Gross margin | 45.5% | 45.8% | 44.4% | 45.5% | 45.2% | 43.6% | 41.9% | 44.1% | 45.7% | 44.7% |
| Operating income | $724.2M | $732.7M | $791.7M | $840.2M | $1.03B | $1.08B | $597.8M | $1.06B | $807.1M | $1.08B |
| Operating margin | 20.7% | 19.4% | 19.1% | 19.3% | 21.0% | 20.8% | 11.1% | 18.0% | 13.2% | 17.4% |
| Net income | $459.0M | $743.4M | $568.6M | $615.9M | $785.9M | $827.5M | $413.9M | $755.6M | $585.3M | $736.8M |
| Net margin | 13.1% | 19.7% | 13.7% | 14.1% | 16.1% | 15.9% | 7.7% | 12.9% | 9.6% | 11.9% |
| EPS (diluted) | $1.75 | $2.90 | $2.27 | $2.44 | $3.12 | $3.32 | $1.68 | $3.05 | $2.37 | $3.02 |
| Balance sheet | ||||||||||
| Cash and equivalents | $187.8M | $278.9M | $316.7M | $155.7M | $183.1M | $240.6M | $270.3M | $344.5M | $964.1M | $409.0M |
| Total assets | $4.35B | $6.01B | $6.07B | $6.66B | $7.41B | $8.00B | $8.35B | $8.57B | $8.88B | $8.91B |
| Total liabilities | $2.38B | $3.80B | $3.62B | $3.99B | $4.39B | $4.76B | $4.86B | $4.71B | $4.52B | $4.91B |
| Long-term debt | $693.4M | $2.10B | $1.51B | $1.81B | $1.81B | $2.20B | $2.60B | $2.20B | $2.20B | $2.21B |
| Shareholders' equity | $1.98B | $2.22B | $2.45B | $2.67B | $3.02B | $3.23B | $3.49B | $3.86B | $4.36B | $4.00B |
| Cash flow | ||||||||||
| Operating cash flow | $655.3M | $681.5M | $763.6M | $864.5M | $990.3M | $993.8M | $885.2M | $1.03B | $1.16B | $1.22B |
| Capital expenditure | $49.8M | $45.0M | $60.4M | $73.7M | $98.9M | $118.8M | $178.8M | $223.5M | $179.8M | $122.4M |
| Free cash flow | $605.5M | $636.5M | $703.2M | $790.8M | $891.4M | $875.0M | $706.4M | $807.1M | $976.4M | $1.09B |
| Dividends paid | $183.0M | $190.4M | $213.3M | $224.1M | $237.3M | $247.5M | $255.0M | $266.5M | $277.0M | $287.2M |
| Share buybacks | $400.0M | $400.0M | $200.0M | $250.0M | $300.0M | $500.0M | $0 | $300.1M | $0 | $900.0M |
RevenueNet income
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.51B | $1.58B | $1.47B | $1.51B | $1.59B | $1.64B | $1.47B | $1.53B |
| Growth (year over year) | +3.8% | +3.5% | −2.4% | −0.3% | +5.0% | +3.9% | +0.1% | +1.6% |
| Gross profit | $683.1M | $707.9M | $659.6M | $647.0M | $714.4M | $753.8M | $681.4M | $693.9M |
| Gross margin | 45.2% | 44.7% | 45.0% | 43.0% | 45.1% | 45.8% | 46.4% | 45.4% |
| Operating income | −$91.5M | $256.7M | $295.3M | $261.7M | $254.6M | $266.0M | $291.0M | $276.4M |
| Operating margin | −6.1% | 16.2% | 20.1% | 17.4% | 16.1% | 16.2% | 19.8% | 18.1% |
| Net income | −$75.1M | $189.2M | $220.1M | $191.0M | $182.2M | $143.5M | $216.3M | $202.8M |
| Net margin | −5.0% | 12.0% | 15.0% | 12.7% | 11.5% | 8.7% | 14.7% | 13.3% |
| EPS (diluted) | −$0.31 | $0.76 | $0.89 | $0.78 | $0.75 | $0.60 | $0.91 | $0.85 |
| Balance sheet | ||||||||
| Cash and equivalents | $752.1M | $964.1M | $1.07B | $923.2M | $305.3M | $409.0M | $503.4M | $254.8M |
| Total assets | $8.67B | $8.88B | $8.96B | $8.79B | $9.14B | $8.91B | $9.01B | $9.11B |
| Total liabilities | $4.47B | $4.52B | $4.40B | $4.39B | $4.92B | $4.91B | $4.82B | $4.76B |
| Long-term debt | $2.21B | $2.20B | $2.21B | $2.21B | $2.20B | $2.21B | $2.21B | $2.21B |
| Shareholders' equity | $4.19B | $4.36B | $4.55B | $4.39B | $4.22B | $4.00B | $4.19B | $4.35B |
| Cash flow | ||||||||
| Operating cash flow | $364.0M | $292.3M | $185.7M | $230.8M | — | — | $174.8M | $286.8M |
| Capital expenditure | $48.6M | $54.6M | $16.5M | $22.5M | $28.2M | $55.2M | $31.9M | $29.9M |
| Free cash flow | $315.4M | $237.7M | $169.2M | $208.3M | — | — | $142.9M | $256.9M |
| Dividends paid | $69.2M | $69.6M | $72.4M | $72.6M | $71.4M | $70.8M | $72.9M | $72.9M |
| Share buybacks | $0 | $0 | — | — | $300.0M | $300.0M | — | — |
From Church & Dwight's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Church & Dwight
Church & Dwight Co., Inc. is an American consumer packaged goods company headquartered in Ewing Township, New Jersey. It manufactures and markets household, personal-care and specialty products in the United States and internationally. The company is best known for Arm & Hammer, whose baking soda and related products trace their origins to a business established by John Dwight and Austin Church in 1846. As of 2026, other major brands include Trojan, OxiClean, Nair, First Response, Orajel, Waterpik, Batiste, TheraBreath, Hero Cosmetics and Touchland.
Source: Wikipedia — Church & Dwight
- Headquarters
- Ewing, New Jersey From SEC filings, Oct 2026
Recent News (11)
-
Is Church & Dwight Stock Outperforming the Dow?
Is Church & Dwight Stock Outperforming the Dow?
-
RFK Jr. to headline Children's Health Defense conference in D.C. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is scheduled to give a keynote address this week at a conference for Children’s Health Defense (CHD), the anti-vaccine advocacy organiza…
-
Church & Dwight EVP Sells 15,375 Shares for $1.6 Million -- Should Investors Beware?
Church & Dwight EVP Sells 15,375 Shares for $1.6 Million -- Should Investors Beware?
-
Renata Medical Closes $25M Series D Financing Led by Global Healthcare Investment Firm ARCHIMED to Accelerate Commercialization and Development of Pediatric Cardiovascular Technologies NEWPORT BEACH, Calif., Aug. 19, 2026 /PRNewswire/ -- Renata Medical, a privately held medical technology company dedicated to transforming care for children with congenital heart disease (CHD), today …
-
Church & Dwight Stock Outlook: Is Wall Street Bullish or Bearish?
Church & Dwight Stock Outlook: Is Wall Street Bullish or Bearish?
-
Two Consumer Staples, Two Dividend Strategies: Church & Dwight (CHD) and The Clorox Company (CLX)
Two Consumer Staples, Two Dividend Strategies: Church & Dwight (CHD) and The Clorox Company (CLX)
-
Church & Dwight director Irwin sells $441,575 in stock
Church & Dwight director Irwin sells $441,575 in stock
-
Church & Dwight (CHD) Q2 2026 Earnings Call Transcript Church & Dwight (CHD) Q2 2026 Earnings Call Transcript
-
Church & Dwight Q2 Earnings Call Highlights Church & Dwight Q2 Earnings Call Highlights
-
Church & Dwight beats revenue estimates on organic growth
Church & Dwight beats revenue estimates on organic growth
-
What to Expect From Church & Dwight's Q2 2026 Earnings Report What to Expect From Church & Dwight's Q2 2026 Earnings Report
More Consumer Staples stocks
- BF.B Brown–Forman
- BG Bunge Global
- CASY Casey's
- CCEP Coca-Cola Europacific Partners
- CL Colgate-Palmolive
- CLX Clorox
- COST Costco
- DG Dollar General